SLC3A2 and cancer: On the contrary, low CD98hc expression is an independent factor for predicting poor overall survival (OS) and progression-free survival (PFS) for patients with cutaneous angiosarcoma (CA) (156), although the small sample size is a limitation of this study since CA is a rare malignant tumor.